N‐Trans Caffeoyltyramine Alleviates Ulcerative Colitis by Targeting FXR to Promote Epithelial Barrier Protection and M2 Macrophage Polarization
Phytotherapy Research · 12.11.2026
DOI: 10.1002/ptr.70520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 12.11.2026. Verfasst von Xianling Ning und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Systems Biomedicine, School of Basic Medical Sciences, Department of Pathology, Beijing Key Laboratory of Tumor Systems Biology, Peking …. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Background and Aim Ulcerative colitis (UC) remains a clinical challenge owing to the complex pathogenesis and lack of curative therapies. Although Cannabis sativa has been associated with alleviating inflammatory bowel disease, the specific active constituents and underlying mechanisms remain poorly defined. The present study aimed to systematically evaluate the anti‐UC effects and mechanisms of two structurally related compounds from C. sativa extracts, N‐trans caffeoyltyramine (NCT), and N‐trans feruloyltyramine (NFT). Experimental Procedure We compared the therapeutic efficacy of NCT and NFT in an acute UC mice model, and investigated the underlying mechanisms using both colonic epithelial cells and macrophages. To validate the involvement of the nuclear receptor FXR, we performed genetic loss‐of‐function approaches to assess the impact on epithelial barrier integrity and macrophage polarization. Key Results NCT is proven superior to NFT in alleviating acute UC. Remarkably, NCT exerts therapeutic efficacy by coordinating two pivotal aspects of UC pathogenesis. It improves tight junction structural integrity through upregulation of tight junction proteins while simultaneously promoting a protective M2 macrophage polarization. Mechanistically, FXR was identified as a key mediator of the effects of NCT, contributing to both barrier enhancement and macrophage phenotype switching. Conclusions and Implications The results provide a molecular rationale for the anti‐UC activity of C. sativa and suggest that NCT alleviates UC, at least in part through FXR‐mediated pathways. These findings support further preclinical development of NCT as a potential therapeutic candidate for UC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Systems Biomedicine, School of Basic Medical Sciences, Department of Pathology, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China.
ORCID-Profile: Xianling Ning, Zhiqiang Lin
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Lam Chung Nin Foundation for Systems Biomedicine
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Ning, X., Chen, M., Zhu, M., Deng, Y., Yuan, Y., Lin, Z., & Yin, Y. (2026). N‐Trans Caffeoyltyramine Alleviates Ulcerative Colitis by Targeting FXR to Promote Epithelial Barrier Protection and M2 Macrophage Polarization. Phytotherapy Research. https://doi.org/10.1002/ptr.70520
Vancouver
Ning X, Chen M, Zhu M, Deng Y, Yuan Y, Lin Z, et al. N‐Trans Caffeoyltyramine Alleviates Ulcerative Colitis by Targeting FXR to Promote Epithelial Barrier Protection and M2 Macrophage Polarization. Phytotherapy Research. 2026. doi:10.1002/ptr.70520
BibTeX
@article{Ning2026,
author = {Ning, Xianling and Chen, Mo and Zhu, Minglu and Deng, Yichen and Yuan, Yuyao and Lin, Zhiqiang and Yin, Yuxin},
title = {N‐Trans Caffeoyltyramine Alleviates Ulcerative Colitis by Targeting FXR to Promote Epithelial Barrier Protection and M2 Macrophage Polarization},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70520}
}
EUVIMED